Haleon (HLN) Projected to Announce Quarterly Earnings on Thursday

Haleon (NYSE:HLN) is projected to announce its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to announce earnings of $0.2669 per share and revenue of $7.4341 billion for the quarter. Interested persons can check the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 2:00 AM ET.

Haleon Trading Down 0.7%

Shares of HLN stock opened at $9.86 on Thursday. Haleon has a 52-week low of $8.65 and a 52-week high of $11.28. The company has a market capitalization of $43.41 billion, a price-to-earnings ratio of 25.27, a PEG ratio of 2.29 and a beta of 0.13. The company has a 50-day simple moving average of $9.33 and a two-hundred day simple moving average of $9.85. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.71 and a current ratio of 0.92.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HLN shares. Wall Street Zen upgraded Haleon from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Finally, Rothschild & Co Redburn cut Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Two analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of HLN. IHT Wealth Management LLC increased its position in Haleon by 6.9% during the fourth quarter. IHT Wealth Management LLC now owns 16,205 shares of the company’s stock valued at $164,000 after acquiring an additional 1,049 shares during the last quarter. National Bank of Canada FI raised its holdings in Haleon by 6.7% in the third quarter. National Bank of Canada FI now owns 17,385 shares of the company’s stock worth $156,000 after purchasing an additional 1,099 shares in the last quarter. Cary Street Partners Financial LLC lifted its holdings in shares of Haleon by 20.1% during the 2nd quarter. Cary Street Partners Financial LLC now owns 6,646 shares of the company’s stock valued at $69,000 after purchasing an additional 1,113 shares during the last quarter. Advisory Services Network LLC boosted its stake in Haleon by 7.1% in the 3rd quarter. Advisory Services Network LLC now owns 17,431 shares of the company’s stock worth $156,000 after purchasing an additional 1,155 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its stake in Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.